Brinda Balakrishnan
Direktor/Vorstandsmitglied bei AURINIA PHARMACEUTICALS INC.
Vermögen: 39 997 $ am 30.04.2024
Aktive Positionen von Brinda Balakrishnan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.01.2016 | - |
AURINIA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 14.06.2021 | - |
Independent Dir/Board Member | 14.06.2021 | - |
Karriereverlauf von Brinda Balakrishnan
Ehemalige bekannte Positionen von Brinda Balakrishnan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Gründer | 01.01.2013 | 01.01.2016 |
Corporate Officer/Principal | 01.01.2013 | 01.01.2016 |
Ausbildung von Brinda Balakrishnan
Massachusetts Institute of Technology | Doctorate Degree |
Harvard Medical School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Kanada | 2 |
Operativ
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Founder | 1 |
Sektoral
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
AURINIA PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Brinda Balakrishnan
- Erfahrung